SCHEMBL30690

SCHEMBL30690

O=C1[C@H](O)C(O)CC12Cc1ccc(Br)cc1C2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 2/20 0.40
CMA1 P23946 1/20 0.35
AHR P35869 1/20 0.35
BRD4 O60885 1/20 0.35
METAP1 P53582 1/20 0.34
KDM1A O60341 1/20 0.33
BACE1 P56817 2/20 0.32
PNMT P11086 4/20 0.31
PARP1 P09874 2/20 0.31
AKR1B1 P15121 1/20 0.31
CYP11B2 P19099 1/20 0.31
PARP10 Q53GL7 2/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
PARP11 Q9NR21 1/20 0.30
ADRA2A P08913 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675644 0.77 TDP2 (0.33) TDP2CMA1AHRBRD4METAP1
SCHEMBL9958538 0.75 TDP2 (0.46) TDP2CMA1AHRBRD4METAP1
SCHEMBL1465235 0.74 CA1 (0.41) TDP2CMA1AHRBRD4METAP1
SCHEMBL7882442 0.74 CA1 (0.41) TDP2CMA1AHRBRD4METAP1
SCHEMBL31076 0.72 BACE1 (0.40) TDP2CMA1AHRMETAP1BACE1
SCHEMBL9958466 0.72 BACE1 (0.40) TDP2CMA1AHRMETAP1BACE1
SCHEMBL17675528 0.70 BACE1 (0.42) TDP2CMA1AHRBRD4BACE1
SCHEMBL11073635 0.68 TDP2 (0.47) TDP2CMA1AHRBRD4METAP1
SCHEMBL30493 0.67 TDP2 (0.39) TDP2CMA1AHRBRD4METAP1
SCHEMBL18543791 0.66 TDP2 (0.36) TDP2CMA1AHRBRD4METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406240-A2 INHIBITORS OF BETA-SECRETASE Vitae Pharmaceuticals, Inc. (US) 2012-01-18 EP disclosed
WO-2010105179-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-09-16 WO disclosed